Abstract

Although the transcription factor serum response factor (SRF) has been suggested to play a role in activity-dependent gene expression and mediate plasticity-associated structural changes in the hippocampus, no unequivocal evidence has been provided for its role in brain pathology, such as epilepsy. A genome-wide program of activity-induced genes that are regulated by SRF also remains unknown. In the present study, we show that the inducible and conditional deletion of SRF in the adult mouse hippocampus increases the epileptic phenotype in the kainic acid model of epilepsy, reflected by more severe and frequent seizures. Moreover, we observe a robust decrease in activity-induced gene transcription in SRF knockout mice. We characterize the genetic program controlled by SRF in neurons and using functional annotation, we find that SRF target genes are associated with synaptic plasticity and epilepsy. Several of these SRF targets function as regulators of inhibitory or excitatory balance and the structural plasticity of neurons. Interestingly, mutations in those SRF targets have found to be associated with such human neuropsychiatric disorders, as autism and intellectual disability. We also identify novel direct SRF targets in hippocampus: Npas4, Gadd45g, and Zfp36. Altogether, our data indicate that proteins that are highly upregulated by neuronal stimulation, identified in the present study as SRF targets, may function as endogenous protectors against overactivation. Thus, the lack of these effector proteins in SRF knockout animals may lead to uncontrolled excitation and eventually epilepsy.Electronic supplementary materialThe online version of this article (doi:10.1007/s12035-014-9089-7) contains supplementary material, which is available to authorized users.

Highlights

  • Epilepsy is a chronic neurological disorder that affects approximately 1 % of the human population [1]

  • We identified 378 activity-dependent Serum response factor (SRF) target genes, among which we distinguished a group with functions associated with epilepsy and synaptic plasticity that may be responsible for the observed phenotype

  • The results of the analysis showed a significant correlation with annotations: Epilepsy (35 genes; p=8.51E−19; Neurological Disease category; e.g., brain-derived neurotrophic factor (Bdnf), Cacna1h, FBJ osteosarcoma oncogene (Fos), growth arrest and DNA-damage-inducible 45 gamma (Gadd45g), zinc finger protein 36 (Zfp36), Cyr61, Egr1, Egr2, and Egr4), Plasticity of Synapse (9 genes; p=0.000103; nervous system development and function category; e.g., Bdnf, Ntrk2, protocadherin 8 (Pcdh8), and Vgf), and Outgrowth of Neurites (21 genes; p=0.0000411; Nervous System Development and Function category; e.g., neuronal PAS domain protein 4 (Npas4), Bdnf, Ntrk2, and Gpr3)

Read more

Summary

Introduction

Epilepsy is a chronic neurological disorder that affects approximately 1 % of the human population [1]. The development of epilepsy (epileptogenesis) involves progressive alterations in synaptic connections (aberrant plasticity), the molecular mechanisms of which are still poorly understood. The regulation of gene transcription by neuronal activity is an integral part of adaptive plasticity [2]. The identification of gene expression programs that result from and control longterm synaptic changes is crucial for understanding the molecular mechanisms that underlie epilepsy [3]. Serum response factor (SRF) is a MADS-box protein that binds DNA at the CC(A/T)6GG consensus sequence, known as a CArG box or serum response element (SRE). SREs are found in promoters of actin cytoskeleton genes and immediate-early genes (IEGs; [4,5,6]). The molecules that are involved in physiological plasticity, such as SRF, may be engaged in pathological or aberrant plasticity processes

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call